TITLE

FDA Actions

PUB. DATE
October 2008
SOURCE
Travel Medicine Advisor;Oct2008 Supplement, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article cites the warnings issued by the U.S. Food and Drug Administration in October 2008. The warnings involved the use of simvastatin by patients taking amiodarone because of the risk of rhabdomyolysis and the use of exenatide and the risk of acute pancreatitis. The flu vaccine is a trivalent vaccine, composed of two Influenza A viruses and one Influenza B virus.
ACCESSION #
34907290

 

Related Articles

  • FDA Actions.  // Infectious Disease Alert;Oct2008 Pharmacology Watch, p2 

    This section offers news on recent actions taken by the U.S. Food and Drug Administration (FDA) as of October 2008. The agency has issued a warning regarding the use of simvastatin in patients who are taking amiodarone regarding the risk of rhabdomyolysis. The FDA also approved six flu vaccines...

  • FDA Actions. Elliott, William T. // Primary Care Reports;Oct2008 Pharmacology, p2 

    The article reports that the U.S. Food and Drug Administration (FDA) has issued warnings for the drugs Simvastatin and Exenatide in October 2008. Patients are being warned not to take simvastatin if they are being treated with amiodarone because it puts them at a higher risk for rhabdomyolysis....

  • Gender Differences with Anticoagulation Discontinuation.  // Travel Medicine Advisor;Oct2008, Vol. 18 Issue 10, p1 

    The article presents an update related to pharmacology as of October 2008. A study by Canadian researchers suggests that women with minimal risk factors may safely stop anticoagulation after six months of therapy, although this does not apply to men. The U.S. Food and Drug Administration (FDA)...

  • FDA Actions.  // Clinical Oncology Alert;Oct2008 Pharmacology Watch, p2 

    The article reports on the warning issued by the U.S. Food and Drug Administration (FDA) regarding the use of simvastatin in patients who are taking amiodarone. Several risks for rhabdomyolysis were found to be associated with statins. The approval of six manufactures of flu vaccines was also...

  • FDA Actions.  // Neurology Alert;Oct2008 Pharmacology Watch, p2 

    This section offers updates on actions taken by the U.S. Food and Drug Administration (FDA) as of October 2008. The FDA has issued a warning regarding the use of simvastatin in patients who are taking amiodarone. The agency has announced the approval of manufactures of flu vaccines, including...

  • Rhabdomyolysis risk with simvastatin plus amiodarone.  // Reactions Weekly;8/16/2008, Issue 1215, p2 

    The article reports on the warning issued by the U.S. Food and Drug Administration that notifies the public of an increased risk of rhabdomyolysis with a combined use of simvastatin and amiodarone. The disease, a condition of muscle injury, can potentially lead to kidney failure or even death....

  • Amiodarone/simvastatin interaction: rhabdomyolysis reported in the US.  // Reactions Weekly;9/27/2008, Issue 1221, p2 

    The article reports that the U.S. Food and Drug Administration (FDA) received 52 reports of rhabdomyolysis associated with the concomitant use of simvastatin and amiodarone between January 1, 2003 and January 2008. The link between rhabdomyolysis and the use of the drugs was based on an analysis...

  • FDA Actions. Elliott, William T. // Clinical Cardiology Alert;Oct2008 Pharmacology Watch, p2 

    The article reports on a warning issued by the U.S. Food & Drug Administration in 2008 regarding the use of simvastatin in patients who are taking amiodarone. It is noted that more than 20 mg of simvastatin plus amiodarone puts patient at higher risk for rhabdomyolysis since amiodarone inhibits...

  • High-dose simvastatin and rhabdomyolysis. Wratchford, Pamela; Ponte, Charles D. // American Journal of Health-System Pharmacy;4/1/2003, Vol. 60 Issue 7, p698 

    Discusses the occurrence of rhabdomyolysis in a patient after an increase in the dosage of simvastin, a form of statins. Use of simvastin for the management of dyslipidemia; Medical history of the patient; Signs and symptoms of rhabdomyolysis.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics